TNF-α promoter polymorphism: A factor contributing to the different immunological and clinical phenotypes in Japanese encephalitis

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Pujhari, Sujit K ^a   Ratho, Radha K ^a   Prabhakar, Sudesh ^a   Mishra, Baijayantimala ^a   Modi, Manish ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; JAPANESE ENCEPHALITIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TNF ALPHA GENE; ADULT; BIOSYNTHESIS; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; INDIA; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS, JAPANESE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84856094231     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-23     Document Type: Article

References (25)

1. Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 2004, 10:S98-S109. 10.1038/nm1144, 15577938.
2. Hanna JN, Ritchie SA, Phillips DA, Lee JM, Hills SL, van den Hurk AF, Pyke AT, Johansen CA, Mackenzie JS. Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust 1999, 170:533-536.
3. Petersen LR, Marfin AA. Shifting epidemiology of Flaviviridae. J Travel Med 2005, 12:S3-S11.
4. Solomon T, Ni H, Beasley DW, Ekkelenkamp M, Cardosa MJ, Barrett AD. Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol 2003, 77:3091-3098. 10.1128/JVI.77.5.3091-3098.2003, 149749, 12584335.
5. Rao P, Joshi K, Mishra B, Ratho RK, Kumar R. An outbreak of Japanese encephalitis in Haryana. J Commun Dis 2005, 37:78-81.
6. Solomon T. Recent advances in Japanese encephalitis. J Neurovirol 2003, 9:274-283.
7. Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol 2001, 75:934-942. 10.1128/JVI.75.2.934-942.2001, 113989, 11134306.
8. Ni H, Barrett AD. Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness. J Gen Virol 1996, 77:1449-1455. 10.1099/0022-1317-77-7-1449, 8757986.
9. Pujhari SK, Prabhakar S, Ratho RK, Modi M, Sharma M, Mishra B. A novel mutation (S227T) in domain II of the envelope gene of Japanese encephalitis virus circulating in North India. Epidemiol Infect 2010, 23:1-8.
10. Ravi V, Parida S, Desai A, Chandramuki A, Gourie-Devi M, Grau GE. Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J Med Virol 1997, 51:132-136. 10.1002/(SICI)1096-9071(199702)51:2<132::AID-JMV8>3.0.CO;2-8, 9021544.
11. Long R, Gardam M. Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection. Cmaj 2003, 168:1153-1156. 153687, 12719321.
12. Thio CL, Goedert JJ, Mosbruger T, Vlahov D, Strathdee SA, O'Brien SJ, Astemborski J, Thomas DL. An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection. Genes Immun 2004, 5:294-300. 10.1038/sj.gene.6364072, 15071492.
13. Karplus TM, Jeronimo SM, Chang H, Helms BK, Burns TL, Murray JC, Mitchell AA, Pugh EW, Braz RF, Bezerra FL, et al. Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection. Infect Immun 2002, 70:6919-6925. 10.1128/IAI.70.12.6919-6925.2002, 133071, 12438370.
14. Li HQ, Li Z, Liu Y, Li JH, Dong JQ, Gao JR, Gou CY, Li H. Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection. World J Gastroenterol 2005, 11:5213-5217.
15. Kim YJ, Lee HS, Yoon JH, Kim CY, Park MH, Kim LH, Park BL, Shin HD. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet 2003, 12:2541-2546. 10.1093/hmg/ddg262, 12915457.
16. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenefelde KH, Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998, 111:579-582. 10.1046/j.1365-2249.1998.00534.x, 1904884, 9528902.
17. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994, 371:508-510. 10.1038/371508a0, 7935762.
18. Swami R, Ratho RK, Mishra B, Singh MP. Usefulness of RT-PCR for the diagnosis of Japanese encephalitis in clinical samples. Scand J Infect Dis 2008, 40:815-820. 10.1080/00365540802227102, 18618334.
19. Hills S, Dabbagh A, Jacobson J, Marfin A, Featherstone D, Hombach J, Namgyal P, Rani M, Solomon T. Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance. BMC Infect Dis 2009, 9:214. 10.1186/1471-2334-9-214, 2809064, 20038298.
20. Du T, Guo XH, Zhu XL, Li JH, Lu LP, Gao JR, Gou CY, Li Z, Liu Y, Li H. Association of TNF-alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population. J Viral Hepat 2006, 13:618-624. 10.1111/j.1365-2893.2006.00731.x, 16907849.
21. Nassif X, Mathison JC, Wolfson E, Koziol JA, Ulevitch RJ, So M. Tumour necrosis factor alpha antibody protects against lethal meningococcaemia. Mol Microbiol 1992, 6:591-597. 10.1111/j.1365-2958.1992.tb01505.x, 1552859.
22. Daffis S, Samuel MA, Suthar MS, Gale M, Diamond MS. Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol 2008, 82:10349-10358. 10.1128/JVI.00935-08, 2573187, 18715906.
23. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 2004, 10:1366-1373. 10.1038/nm1140, 15558055.
24. Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, Wheeler CM. TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis 2005, 191:969-976. 10.1086/427826, 15717274.
25. Biswas SM, Kar S, Singh R, Chakraborty D, Vipat V, Raut CG, Mishra AC, Gore MM, Ghosh D. Immunomodulatory cytokines determine the outcome of Japanese encephalitis virus infection in mice. J Med Virol 2010, 82:304-310. 10.1002/jmv.21688, 20029807.